Benefits
Applied to the face: comparable to retinol for photoageing in one 12 week trial
In the one verified human trial, 44 adults with mild to moderate facial photoageing used 0.5% bakuchiol cream twice a day or 0.5% retinol cream once a day for 12 weeks. Both creams reduced wrinkle surface area and pigmentation, with no significant difference between them, and the retinol group reported more scaling and stinging. The trial had no placebo or untreated group, so some of the improvement in both arms could come from moisturising alone. Everything was applied to the skin, so none of this supports swallowing bakuchi seed. Laboratory work suggests bakuchiol acts like a retinoid without binding retinoid receptors, but that has only been seen in cells.
Well tolerated on sensitive skin in a small open label study
In a 4 week open label study, 60 women aged 40 to 65 with sensitive skin (eczema, rosacea or cosmetic intolerance) used a bakuchiol cleanser and moisturizer and showed better skin barrier readings, more hydration and some improvement in photoageing signs, with no irritation reported. There was no placebo or comparison group, the study lasted only 4 weeks, and everyone used finished commercial products, so the changes cannot be credited to bakuchiol itself. This study is also not among the page's verified references.
Activity against acne bacteria in laboratory tests only
In laboratory culture bakuchiol slows the growth of Cutibacterium acnes, the bacterium involved in acne, limits the growth of oil gland cells and damps inflammatory signalling in cells. Some cosmetic products include it for that reason. No human acne trial is cited on this page, so this is a test tube finding rather than a shown effect on anyone's skin, and acne that needs treatment is a job for a clinician.
Traditional Ayurvedic use for pigment loss (no modern trial cited)
Psoralea corylifolia has been used in Ayurveda for centuries for loss of skin pigment. The psoralens in the raw seed (they are not present in purified bakuchiol) react with ultraviolet light in the same way as the drugs used in medical PUVA phototherapy. That is precisely why raw seed preparations are risky outside a supervised clinic: the same chemistry can cause severe burns and blistering. No modern controlled trial of bakuchi for pigment loss is cited on this page, and pigment disorders are a medical matter for a dermatologist rather than something to self treat with a herb.
Antioxidant and anti-inflammatory mechanisms
In test tube assays bakuchiol mops up reactive oxygen species and dampens NF-kB inflammatory signalling, and in some of those assays its antioxidant capacity falls in a similar range to vitamin E. These are chemical and cell measurements. No study cited on this page measured antioxidant status or inflammation in people, by any route.
Mechanism of action
Retinol-like gene activity in cultured skin cells, without retinoid receptor binding
In human skin cells grown in a dish, a gene microarray study found bakuchiol changed the activity of 71 of the same genes as retinol, including genes for type I, III and IV collagen. This was a laboratory experiment, not a study in people. Critically: bakuchiol does not bind retinoic acid receptors (RAR/RXR) directly. Mechanism is retinoid-mimetic through an unknown alternative pathway, possibly involving downstream MAPK or AP-1 signaling. This is a proposed explanation for the lower rate of scaling and stinging seen in the face cream trial, not a proven pathway.
Anti-inflammatory NF-κB inhibition
Bakuchiol inhibits NF-κB activation, reducing TNF-α, IL-1β, and COX-2 expression. These are cell culture findings. No cited study measured inflammation in people, and nothing cited here compared bakuchiol with any anti-inflammatory medicine.
Antimicrobial activity (P. acnes selective)
In laboratory culture bakuchiol inhibits Cutibacterium acnes (formerly Propionibacterium acnes) and is less active against gram negative bacteria. Whether this matters on real skin has not been tested in any study cited here, and nothing cited compared bakuchiol with benzoyl peroxide or measured the skin microbiome.
Antioxidant via direct radical scavenging
Phenol structure provides direct hydroxyl and peroxyl radical scavenging. Lipid-phase compatible (unlike vitamin C). In some chemical assays its antioxidant capacity per molecule is comparable to or higher than vitamin E. These are test tube measurements, and no cited study measured an antioxidant effect on human skin.
Clinical trials
Prospective, randomized, double-blind assessment (Dhaliwal S, Rybak I, Ellis SR, Notay M, Trivedi M, Burney W, Vaughn AR, Nguyen M, Reiter P, Bosanac S, Yan H, Foolad N, Sivamani RK 2019, Br J Dermatol 180(2):289-296, doi:10.1111/bjd.16918).
44 women with mild-to-moderate facial photoaging randomized to 0.5% bakuchiol cream applied twice daily OR 0.5% retinol cream applied once daily for 12 weeks. Primary endpoints: wrinkle surface area, hyperpigmentation. Secondary: tolerability.
Both treatments significantly decreased wrinkle surface area and hyperpigmentation with NO statistical difference between groups. However, retinol users reported significantly more facial skin scaling and stinging adverse events than bakuchiol users. The authors concluded that the bakuchiol cream was comparable to retinol for photoageing and better tolerated. Limitations: 44 participants, all women, 12 weeks, and no placebo or untreated arm, so part of the improvement in both groups could come from moisturising alone. Both products were applied to the skin, so the trial says nothing about taking bakuchi by mouth.
Mechanistic study + clinical case study (Chaudhuri RK, Int J Cosmet Sci 36(3):221-230, doi:10.1111/ics.12117).
DNA microarray comparing bakuchiol vs retinol gene expression effects in human dermal fibroblasts. Plus clinical evaluation: bakuchiol formulated into finished skin care product, applied twice-a-day to face for 12 weeks.
Bakuchiol regulated 71 retinoid-like genes including upregulation of types I, III, IV collagen. Volcano plots showed great overall similarity of retinol and bakuchiol effects on gene expression profile. The skin care portion was an uncontrolled evaluation of a finished cosmetic product used on the face for 12 weeks, with no placebo group and no comparison arm, so the reported improvements cannot be separated from the rest of the formula or from routine moisturising. The gene work was done in cells, not people. This paper is also not among the page's verified references, and it supports a proposed retinoid like mechanism rather than establishing one.
Open-label clinical evaluation (Draelos ZD, Gunt H, Zeichner J, J Drugs Dermatol 19(12):1181-1183, doi:10.36849/JDD.2020.5522).
60 female subjects Fitzpatrick I-V, ages 40-65 with sensitive skin (1/3 eczema/atopic dermatitis, 1/3 rosacea, 1/3 cosmetic intolerance syndrome) and mild-moderate photodamage. 4-week study using bakuchiol cleanser + moisturizer twice daily.
Improved skin barrier (decreased TEWL), increased hydration (corneometry), and improved photoaging signs across all sensitive skin subgroups. No irritation was reported. The study was open label with no placebo or comparison group, ran only 4 weeks, and participants used finished commercial products, so the results cannot be credited to bakuchiol on its own. It is not among the page's verified references, and "broadening an indication" is not something a cosmetic study can do.